HPV vaccination of immunocompromised hosts

Download
Author
Garland, SM; Brotherton, JML; Moscicki, AB; Kaufmann, AM; Stanley, M; Bhatla, N; Sankaranarayanan, R; de Sanjose, S; Palefsky, JMDate
2017-12-01Source Title
Papillomavirus ResearchPublisher
ELSEVIER SCIENCE BVAffiliation
Melbourne School of Population and Global HealthObstetrics and Gynaecology
Metadata
Show full item recordDocument Type
Journal ArticleCitations
Garland, S. M., Brotherton, J. M. L., Moscicki, A. B., Kaufmann, A. M., Stanley, M., Bhatla, N., Sankaranarayanan, R., de Sanjose, S. & Palefsky, J. M. (2017). HPV vaccination of immunocompromised hosts. PAPILLOMAVIRUS RESEARCH, 4, pp.35-38. https://doi.org/10.1016/j.pvr.2017.06.002.Access Status
Open AccessAbstract
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.
Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References